KATHERINE WALZ: Open Payments
NPI 1447642624 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 19 payments from 13 companies in 2025. Trend: 2023 $800 · 2024 $262 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Medtronic, Inc. | 1 | $42 |
| ABBVIE INC. | 2 | $41 |
| Soleno Therapeutics, Inc. | 1 | $31 |
| Amgen Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Renalytix AI, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: XIFAXAN, COREVALVE EVOLUT R, Wegovy, VYKAT XR, QULIPTA, Dexcom G6 Transmitter, Veozah, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT.
Industry payments across AZ — which companies pay providers there.
